Journal
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
Volume 38, Issue 12, Pages 796-803Publisher
WILEY-BLACKWELL
DOI: 10.1111/j.1440-1681.2011.05609.x
Keywords
hypoxia; l-arginine; nitric oxide synthase; pulmonary hypertension
Categories
Funding
- National Heart, Lung, and Blood Institute [R01HL075261]
Ask authors/readers for more resources
1. The endogenous production of and/or the bioavailability of nitric oxide (NO) is decreased in pulmonary hypertensive diseases. l-arginine (l-arg) is the substrate for NO synthase (NOS). l-arg is transported into cells via the cationic amino acid transporters (CAT), of which there are two isoforms in endothelial cells, CAT-1 and CAT-2.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available